Imunon, Inc. financial data

Symbol
IMNN on Nasdaq
Location
997 Lenox Drive, Suite 100, Lawrenceville, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 136 % -39%
Debt-to-equity 200 % +156%
Return On Equity -501 % -118%
Return On Assets -167 % -29.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.07M shares -78.8%
Common Stock, Shares, Outstanding 2.9M shares -80%
Entity Public Float 10.8M USD -9.24%
Common Stock, Value, Issued 29K USD -80%
Weighted Average Number of Shares Outstanding, Basic 2.94M shares +128%
Weighted Average Number of Shares Outstanding, Diluted 2.94M shares +128%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.52M USD -41.9%
General and Administrative Expense 7.01M USD -12.3%
Operating Income (Loss) -14.5M USD +30.6%
Nonoperating Income (Expense) 46.7K USD -59.7%
Net Income (Loss) Attributable to Parent -14.3M USD +26.3%
Earnings Per Share, Basic 6 USD/shares +69.1%
Earnings Per Share, Diluted 6 USD/shares +69.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.25M USD -49.1%
Cash, Cash Equivalents, and Short-term Investments 5.3M USD -48.5%
Assets, Current 7.26M USD -42.1%
Other Long-term Investments 3.75M USD -37.5%
Deferred Income Tax Assets, Net 1.28M USD -18.3%
Property, Plant and Equipment, Net 601K USD +6.71%
Operating Lease, Right-of-Use Asset 1.08M USD -13.4%
Other Assets, Noncurrent 1.13M USD -12.9%
Assets 8.99M USD -37.5%
Accounts Payable, Current 3.52M USD -1.99%
Employee-related Liabilities, Current 1.69M USD +15.9%
Accrued Liabilities, Current 2.68M USD +4.02%
Liabilities, Current 4.2M USD -22.9%
Operating Lease, Liability, Noncurrent 708K USD -6.55%
Liabilities 4.91M USD -20.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 133K USD +7.45%
Retained Earnings (Accumulated Deficit) -417M USD -3.56%
Stockholders' Equity Attributable to Parent 4.08M USD -50.2%
Liabilities and Equity 8.99M USD -37.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.85M USD +51.5%
Net Cash Provided by (Used in) Financing Activities 106K USD
Net Cash Provided by (Used in) Investing Activities -260K USD -111%
Common Stock, Shares Authorized 350M shares +211%
Common Stock, Shares, Issued 2.9M shares -80%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3M USD +14.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.84M USD -66.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 180K USD -95.7%
Deferred Tax Assets, Valuation Allowance 74.6M USD +2.27%
Deferred Tax Assets, Gross 74.6M USD +0.51%
Operating Lease, Liability 1.1M USD -12.9%
Depreciation 66.7K USD -5.15%
Payments to Acquire Property, Plant, and Equipment 260K USD +2109%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.7M USD +13.4%
Lessee, Operating Lease, Liability, to be Paid 1.26M USD -14.2%
Property, Plant and Equipment, Gross 1.74M USD -39.1%
Operating Lease, Liability, Current 394K USD -22.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 498K USD +37.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 489K USD -9.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 1.28M USD -18.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 155K USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three 370K USD +2%
Deferred Tax Assets, Operating Loss Carryforwards 66.1M USD -1.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 370K USD
Operating Lease, Payments 662K USD +3.42%
Additional Paid in Capital 421M USD +2.52%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 193K USD +10.7%
Deferred Tax Assets, Net of Valuation Allowance 1.28M USD -18.3%
Interest Expense 37.1K USD -64.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%